Valuation (31%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 312.32 | 37.05 |
PEG Ratio (TTM) | 2.54 | 11.98 |
P/S Ratio (TTM) | 7.54 | 14.61 |
P/B Ratio (TTM) | 3.54 | 18.78 |
P/FCF Ratio (TTM) | 34.77 | 42.97 |
Price to 5YR AVG Earnings Ratio | N/A | 32.96 |
Price to 5YR AVG FCF Ratio | N/A | 63.36 |
Profitability (20%) |
Company | Industry |
---|---|---|
ROA (TTM) | 0.70% | 12.20% |
ROE (TTM) | 1.15% | -7.48% |
Net Profit Margin (TTM) | 2.36% | 24.97% |
ROIC 5YR AVG | N/A | 4.50% |
Growth (35%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 358.51% | -438.26% | N/A |
Revenue | 2.40% | 8.39% | N/A |
Net Income | 361.71% | -389.19% | N/A |
Cash Flow | -3.02% | 45.42% | N/A |
Health (67%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 2.66 | 1.43 |
Quick Ratio (TTM) | 2.66 | 1.41 |
D/E Ratio (TTM) | 0.41 | 1.24 |
Interest Coverage (TTM) | 0.96 | 35.48 |
Piotroski F-Score | 6 | 6 |
Altman Z-Score | 3.52 | 9.32 |
LTL to 5YR AVG FCF | N/A | 5.27 |
Shares Outstanding Growth 5YR AVG | N/A | 0.66% |